Description: Indication: Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control, when dual sitagliptin and metformin HCl therapy is appropriate (i.e, high initial HbA1c levels and poor prospects of response to monotherapy)